Silverback Therapeutics I... (SBTX)

NASDAQ: SBTX · Real-Time Price · USD

5.87

0.06 (1.03%)

At close: Nov 09, 2022, 5:00 AM

Silverback Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	-54.37M	-34.68M	-89.48M	-32.95M	-23.97M	-17.58M
Depreciation & Amortization	73K	319K	783K	637K	544K	480K
Stock-Based Compensation	n/a	n/a	n/a	n/a	n/a	n/a
Other Working Capital	n/a	10.29M	-4.43M	-4.42M	3.3M	-433K
Other Non-Cash Items	n/a	-1.27M	1.15M	1.1M	1.08M	364K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	n/a	-10.29M	1.6M	-2.63M	3.3M	-433K
Operating Cash Flow	-59.27M	-40.08M	-66.76M	-31.2M	-18.9M	-16.88M
Capital Expenditures	-175K	-199K	-1.37M	-917K	-96K	-449K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-272M	n/a	-65.11M	n/a	n/a	n/a
Sales Maturities Of Investments	185M	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-87.18M	-199K	-66.48M	-917K	-96K	-449K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	1.46M	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	6.9M	190.73M	614K	408.51M	8.61M	19.4M
Financial Cash Flow	6.9M	190.73M	614K	408.51M	8.61M	19.4M
Net Cash Flow	-139.55M	150.46M	-132.62M	376.39M	-10.38M	2.08M
Free Cash Flow	-59.44M	-40.28M	-68.13M	-32.11M	-18.99M	-17.32M